Mannheim, Germany

Claudia Packhaeuser


 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Claudia Packhaeuser: Innovator in Pharmaceutical Dosage Forms

Introduction

Claudia Packhaeuser is a notable inventor based in Mannheim, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. Her work focuses on improving the administration of medications for treating proliferative disorders.

Latest Patents

Claudia holds 1 patent for her invention titled "Pharmaceutical dosage form for oral administration of a bcl 2 family inhibitor." This invention relates to a pharmaceutical dosage form that comprises a solid dispersion product containing a specific compound and at least one pharmaceutically acceptable polymer and solubilizer. The invention also includes processes for preparing the dosage form and its use in treating various proliferative disorders.

Career Highlights

Throughout her career, Claudia has worked with prominent companies in the pharmaceutical industry, including AbbVie Inc. and AbbVie Deutschland GmbH & Co. KG. Her experience in these organizations has allowed her to contribute to significant advancements in drug formulation and delivery.

Collaborations

Claudia has collaborated with esteemed colleagues such as Norbert Steiger and Bernd Liepold. These partnerships have further enhanced her research and development efforts in the pharmaceutical sector.

Conclusion

Claudia Packhaeuser is a pioneering inventor whose work in pharmaceutical dosage forms has the potential to improve treatment options for patients with proliferative disorders. Her contributions to the field exemplify the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…